On the first day of New Jersey adult-use cannabis sales, the 12 adult-use dispensaries locations sold cannabis products to 12,438 adult-use customers for nearly $1.9 million.
The New Jersey Cannabis Regulatory Commission (NJCRC) reported that sales of medical cannabis products have also been strong over the last 30 days, with approximately 64,000 ounces of products dispensed to patients and their caregivers.
On 4/20, the day before New Jersey adult-use cannabis sales began, ATCs dispensed 5,400 ounces of medical cannabis to New Jersey patients.
In the five days following the beginning of adult-use sales, 7,500 ounces were dispensed to patients.
“We expected sales to be substantial, and the data shows that the market is effectively serving both adult-use consumers and patients,” said NJCRC Executive Director Jeff Brown. “We continue to monitor inventory and access for patients and are prepared to take enforcement action against any ATC that does not meet the requirements for patient access and supply.”
While lines have been steady at all the dispensaries, there have not been any legitimate reports of supply problems for medicinal cannabis patients. The NJCRC continues to monitor and respond to complaints to ensure patients have adequate supply and access.
The Multi-State Operator (MSO) Massachusetts-based corporation Curaleaf was initially very eager to make it 13 adult-use cannabis locations, but they have yet to do so. It remains unclear why.